References
- Friedland RP: Alzheimer's disease: Clinical features and differential diagnosis. Neurology 1993; 43: S45–S51.
- http://www.alz.org/Resources/FactSheets/FSAlzheimerStats.pdf. Last updated: May 15, 2005.
- Benson DF, Davis J, Snyder BD: Posterior cortical atrophy. Arch Neurol 1988; 45: 789–793.
- Mendez MF, Mendez MA, Martin R, Smyth KA, Whitehouse PJ: Complex visual disturbances in Alzheimer's disease. Neurology 1990; 40: 439–443.
- Brun A, Englund E: Regional pattern of degeneration in Alzheimer's disease: Neuronal loss and histopathological grading. Histopathology 1981; 5: 549–564.
- Lewis DA, Campbell MJ, Terry RD, Morrison JH: Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J Neurosci 1987; 7: 1799–1808.
- Cogan DG: Visuospatial dysgnosia. Am J Ophthalmol 1979; 88: 361–368.
- Cogan DG: Visual disturbances with focal progressive dementing disease. Am J Ophthalmol 1985; 100: 68–72.
- Mendez MF, Tomsak RL, Remler B: Disorders of the visual system in Alzheimer's disease. J Clin Neuroophthalmol 1990; 10: 62–69.
- Sadun AA, Borchert M, DeVita E, Hinton DR, Bassi CJ: Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmol 1987; 104: 113–120.
- Fletcher WA, Sharpe JA: Saccadic eye movement dysfunction in Alzheimer's disease. Ann Neurol 1986; 20: 464–471.
- Currie J, Ramsden B, McArthur C, Maruff P: Validation of a clinical antisaccade eye movement test in the assessment of dementia. Arch Neurol 1991; 48: 644–648.
- Hecaen H, de Ajuriaguerra J: Balint's syndrome (psychic paralysis of visual fixation) and its minor forms. Brain 1954; 77: 373–400.
- Hinton DR, Sadun AA, Blanks JC, and Miller C: Optic nerve degeneration in Alzheimer's disease. N Engl J Med 1986; 315: 485–487.
- Kiyosawa M, Bosley TM, Chawluk J, Jamieson D, Schatz NJ, Savino PJ, Sergott RC, Reivich M, Alavi A: Alzheimer's disease with prominent visual symptoms: Clinical and metabolic evaluation. Ophthalmology 1989; 96: 1077–1086.
- Lang AE, Lozano AM: Parkinson's disease: First of two parts. N Engl J Med 1998; 339: 1044–1053.
- Lang AE, Lozano AM: Parkinson's disease: Second of two parts. N Engl J Med 1998; 339: 1130–1143.
- Bodis-Wollner I: Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci 1990; 13: 296–302.
- Peppe A, Stanzione P, Pierelli F, DeAngelis D, Pierantozzi M, Bernardi G: Visual alterations in de novo Parkinson's disease: Pattern Electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 1995; 45: 1144–1148.
- Price MJ, Felman RG, Adelerg D, Kayne H: Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992; 42: 887–890.
- Biousee V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ: Ophthalmologic features of Parkinson's disease. Neurology 2004; 62: 177–180.
- Karson CN, LeWitt PA, Calne DB, Wyatt RJ: Blink rates in Parkinsonism. Ann Neurol 1982; 12: 580–583.
- Corin MS, Elizan TS, Bender MB: Oculomotor function in patients with movements in Parkinson's disease. J Neurol Sci 1971; 15: 251–265.
- Repka MX, Claro MC, Loupe DN, Reich SG: Ocular motility in Parkinson's disease. J Pediatr Ophthalmol Strabismus 1996; 33: 144–147.
- Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC: Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38: 1031–1034.
- Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ: The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001; 124: 1438–1449.
- Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964; 10: 333–359.
- Friedman DI, Jankovic J, McCrary JA III: Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuroophthalmol 1992; 12: 104–108.